
The Korean Cannabinoid Association plans to use blockchain technology to carry out some studies on cannabidiol. The Korean Cannabinoid Association (KCA) announced during a conference last week in Seoul that it will begin clinical studies on cannabidiol (CBD), a constituent drug of cannabis used in chronic neurological disease therapies such as multiple sclerosis. The project [...]